Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
CA BOTANA International, Inc.
CGMP Deviations
Safecor Health, LLC
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
Atlantiscan
Packaging. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns…
STAQ Pharma, Inc.
Labeling: Incorrect or Missing Lot and/or Exp Date
Amerisource Health Services LLC
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that …
STAQ Pharma, Inc.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma, Inc.
Labeling: Incorrect or Missing Lot and/or Exp Date
ibspot
Marketed Without an Approved NDA/ANDA
USV Private Limited
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.
ASTRAZENECA PHARMACEUTICALS
Lack of Assurance of Sterility:
Mohamed Hagar
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Sandoz Lisinopril HCT 20/25mg
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Rising Pharma Holding, Inc.
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) inst…
Teva Pharmaceuticals USA, Inc
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit fo…